vs

Side-by-side financial comparison of Clorox (CLX) and Jacobs Solutions (J). Click either name above to swap in a different company.

Jacobs Solutions is the larger business by last-quarter revenue ($3.3B vs $1.7B, roughly 2.0× Clorox). Clorox runs the higher net margin — 9.4% vs 3.8%, a 5.6% gap on every dollar of revenue. On growth, Jacobs Solutions posted the faster year-over-year revenue change (12.3% vs 0.3%). Over the past eight quarters, Clorox's revenue compounded faster (-8.3% CAGR vs -12.2%).

The Clorox Company is an American multinational manufacturer and marketer of consumer and professional products. Clorox ranked annually on the Fortune 500 list from 2000 to 2024, where it last held the #485 spot.

Jacobs Solutions Inc. is an American international technical professional services firm based in Dallas. The company provides engineering, technical, professional, and construction services as well as scientific and specialty consulting for a broad range of clients globally, including companies, organizations, and government agencies. Jacobs has consistently ranked No.

CLX vs J — Head-to-Head

Bigger by revenue
J
J
2.0× larger
J
$3.3B
$1.7B
CLX
Growing faster (revenue YoY)
J
J
+12.0% gap
J
12.3%
0.3%
CLX
Higher net margin
CLX
CLX
5.6% more per $
CLX
9.4%
3.8%
J
Faster 2-yr revenue CAGR
CLX
CLX
Annualised
CLX
-8.3%
-12.2%
J

Income Statement — Q2 FY2026 vs Q1 FY2026

Metric
CLX
CLX
J
J
Revenue
$1.7B
$3.3B
Net Profit
$157.0M
$125.5M
Gross Margin
43.2%
23.2%
Operating Margin
7.1%
Net Margin
9.4%
3.8%
Revenue YoY
0.3%
12.3%
Net Profit YoY
-15.6%
792.3%
EPS (diluted)
$1.29
$1.12

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLX
CLX
J
J
Q4 25
$1.7B
$3.3B
Q3 25
$3.2B
Q2 25
$2.0B
$3.0B
Q1 25
$1.7B
$2.9B
Q4 24
$1.7B
$2.9B
Q3 24
$1.8B
$-1.2B
Q2 24
$1.9B
$4.2B
Q1 24
$1.8B
$4.3B
Net Profit
CLX
CLX
J
J
Q4 25
$157.0M
$125.5M
Q3 25
$122.2M
Q2 25
$332.0M
$179.6M
Q1 25
$186.0M
$5.6M
Q4 24
$193.0M
$-18.1M
Q3 24
$99.0M
$325.4M
Q2 24
$216.0M
$146.9M
Q1 24
$-51.0M
$162.1M
Gross Margin
CLX
CLX
J
J
Q4 25
43.2%
23.2%
Q3 25
24.3%
Q2 25
46.5%
25.0%
Q1 25
44.6%
25.4%
Q4 24
43.8%
24.6%
Q3 24
45.8%
Q2 24
46.5%
21.7%
Q1 24
42.2%
21.2%
Operating Margin
CLX
CLX
J
J
Q4 25
7.1%
Q3 25
6.7%
Q2 25
20.6%
7.8%
Q1 25
15.2%
7.2%
Q4 24
14.1%
7.1%
Q3 24
10.0%
Q2 24
14.5%
6.2%
Q1 24
-2.3%
6.6%
Net Margin
CLX
CLX
J
J
Q4 25
9.4%
3.8%
Q3 25
3.9%
Q2 25
16.7%
5.9%
Q1 25
11.2%
0.2%
Q4 24
11.4%
-0.6%
Q3 24
5.6%
-28.1%
Q2 24
11.4%
3.5%
Q1 24
-2.8%
3.8%
EPS (diluted)
CLX
CLX
J
J
Q4 25
$1.29
$1.12
Q3 25
$0.88
Q2 25
$2.68
$1.55
Q1 25
$1.50
$0.06
Q4 24
$1.54
$-0.11
Q3 24
$0.80
$2.50
Q2 24
$1.74
$1.17
Q1 24
$-0.41
$1.28

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLX
CLX
J
J
Cash + ST InvestmentsLiquidity on hand
$227.0M
$1.6B
Total DebtLower is stronger
Stockholders' EquityBook value
$-125.0M
$3.4B
Total Assets
$5.6B
$11.6B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLX
CLX
J
J
Q4 25
$227.0M
$1.6B
Q3 25
$1.2B
Q2 25
$167.0M
$1.3B
Q1 25
$226.0M
$1.2B
Q4 24
$290.0M
$1.3B
Q3 24
$278.0M
$1.1B
Q2 24
$202.0M
$1.2B
Q1 24
$219.0M
$1.0B
Total Debt
CLX
CLX
J
J
Q4 25
Q3 25
Q2 25
$2.5B
Q1 25
Q4 24
Q3 24
Q2 24
$2.5B
Q1 24
Stockholders' Equity
CLX
CLX
J
J
Q4 25
$-125.0M
$3.4B
Q3 25
$3.6B
Q2 25
$321.0M
$3.8B
Q1 25
$27.0M
$3.9B
Q4 24
$-41.0M
$4.2B
Q3 24
$60.0M
$4.5B
Q2 24
$328.0M
$6.6B
Q1 24
$91.0M
$6.6B
Total Assets
CLX
CLX
J
J
Q4 25
$5.6B
$11.6B
Q3 25
$11.3B
Q2 25
$5.6B
$11.4B
Q1 25
$5.5B
$11.2B
Q4 24
$5.6B
$11.6B
Q3 24
$5.5B
$11.8B
Q2 24
$5.8B
$15.0B
Q1 24
$5.8B
$14.9B
Debt / Equity
CLX
CLX
J
J
Q4 25
Q3 25
Q2 25
7.74×
Q1 25
Q4 24
Q3 24
Q2 24
7.56×
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLX
CLX
J
J
Operating Cash FlowLast quarter
$380.8M
Free Cash FlowOCF − Capex
$364.9M
FCF MarginFCF / Revenue
11.1%
Capex IntensityCapex / Revenue
0.5%
Cash ConversionOCF / Net Profit
3.03×
TTM Free Cash FlowTrailing 4 quarters
$875.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLX
CLX
J
J
Q4 25
$380.8M
Q3 25
$383.1M
Q2 25
$294.0M
$292.6M
Q1 25
$286.0M
$-96.4M
Q4 24
$180.0M
$107.5M
Q3 24
$221.0M
$196.5M
Q2 24
$340.0M
$482.6M
Q1 24
$182.0M
$-42.8M
Free Cash Flow
CLX
CLX
J
J
Q4 25
$364.9M
Q3 25
$353.5M
Q2 25
$219.0M
$270.5M
Q1 25
$233.0M
$-113.7M
Q4 24
$127.0M
$97.1M
Q3 24
$182.0M
$158.2M
Q2 24
$259.0M
$444.9M
Q1 24
$127.0M
$-70.6M
FCF Margin
CLX
CLX
J
J
Q4 25
11.1%
Q3 25
11.2%
Q2 25
11.0%
8.9%
Q1 25
14.0%
-3.9%
Q4 24
7.5%
3.3%
Q3 24
10.3%
-13.6%
Q2 24
13.6%
10.5%
Q1 24
7.0%
-1.7%
Capex Intensity
CLX
CLX
J
J
Q4 25
0.5%
Q3 25
0.9%
Q2 25
3.8%
0.7%
Q1 25
3.2%
0.6%
Q4 24
3.1%
0.4%
Q3 24
2.2%
-3.3%
Q2 24
4.3%
0.9%
Q1 24
3.0%
0.7%
Cash Conversion
CLX
CLX
J
J
Q4 25
3.03×
Q3 25
3.13×
Q2 25
0.89×
1.63×
Q1 25
1.54×
-17.18×
Q4 24
0.93×
Q3 24
2.23×
0.60×
Q2 24
1.57×
3.28×
Q1 24
-0.26×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLX
CLX

Health And Wellness$643.0M38%
Household$419.0M25%
Lifestyle$321.0M19%
Other$290.0M17%

J
J

Infrastructure Advanced Facilities$2.9B89%
PA Consulting$354.4M11%

Related Comparisons